Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice

Cerebral Cortex

Volumn 20, Issue 8, 2010, Pages 1955-1963

  Brigman, Jonathan L ^a   Mathur, Poonam ^a   Harvey White, Judith ^b   Izquierdo, Alicia ^a   Saksida, Lisa M ^c,d   Bussey, Timothy J ^c,d   Fox, Stephanie ^e   Deneris, Evan ^e   Murphy, Dennis L ^f   Holmes, Andrew ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UK   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

antidepressant; executive function; gene; reversal; serotonin

Indexed keywords

FENCLONINE; FLUOXETINE; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE LOSS; GENETIC VARIABILITY; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; VISUAL DISCRIMINATION; VISUAL STIMULATION;

ANIMALS; BRAIN CHEMISTRY; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOWN-REGULATION; FENCLONINE; FLUOXETINE; GENE SILENCING; LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL PLASTICITY; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 77955978981     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhp266     Document Type: Article

References (62)

1. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP. 1998. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxy-methamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol. 53:649-655.
2. Boulougouris V, Glennon JC, Robbins TW. 2008. Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology. 33:2007-2019.
3. Boyce-Rustay JM, Holmes A. 2006. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic-and antidepressant-like effects in mice. Neuropsychopharmacology. 31:2405-2414.
4. Boyce-Rustay JM, Palachick B, Hefner K, Chen YC, Karlsson RM, Millstein RA, Harvey-White J, Holmes A. 2008. Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress. Neuropharmacology. 55:803-811.
5. Brigman J, Graybeal C, Holmes A. Forthcoming. Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia. Front Neurosci.
6. Brigman JL, Feyder M, Saksida LM, Bussey TJ, Mishina M, Holmes A. 2008. Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn Mem. 15:50-54.
7. Brigman JL, Ihne J, Saksida LM, Bussey TJ, Holmes A. 2009. Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL/6J mice. Front Behav Neurosci. 3:2.
8. Canli T, Lesch KP. 2007. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. 10:1103-1109.
9. Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C. 2008. Identifying molecular substrates in a mouse model of the serotonin transporter 3 environment risk factor for anxiety and depression. Biol Psychiatry. 63:840-846.
10. Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, Holmes A. 2007. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet. 37:214-222.
11. Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, et al. 2008. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry. 64:4-10.
12. Caspi A, Moffitt TE. 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci. 7:583-590.
13. Chamberlain SR, Muller U, Robbins TW, Sahakian BJ. 2006. Neurophar-macological modulation of cognition. Curr Opin Neurol. 19: 607-612.
14. Chudasama Y, Robbins TW. 2003. Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. J Neurosci. 23:8771-8780.
15. Clark L, Cools R, Robbins TW. 2004. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn. 55:41-53.
16. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. 2004. Cognitive inflexibility after prefrontal serotonin depletion. Science. 304:878-880.
17. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. 2005. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci. 25:532-538.
18. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC. 2007. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex. 17:18-27.
19. Cryan JF, Holmes A. 2005. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov. 4:775-790.
20. Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. 2004. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA. 101:8186-8191.
21. Dalley JW, Cardinal RN, Robbins TW. 2004. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 28:771-784.
22. Dalley JW, Mar AC, Economidou D, Robbins TW. 2008. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav. 90:250-260.
23. Daws LC, Montanez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A. 2006. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci. 26:6431-6438.
24. Esaki T, Cook M, Shimoji K, Murphy DL, Sokoloff L, Holmes A. 2005. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci USA. 102:5582-5587.
25. Evers EA, Cools R, Clark L, van der Veen FM, Jolles J, Sahakian BJ, Robbins TW. 2005. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuro-psychopharmacology. 30:1138-1147.
26. Finger EC, Marsh AA, Buzas B, Kamel N, Rhodes R, Vythilingham M, Pine DS, Goldman D, Blair JR. 2007. The impact of tryptophan depletion and 5-HTTLPR genotype on passive avoidance and response reversal instrumental learning tasks. Neuropsychopharma-cology. 32:206-215.
27. Fratta W, Biggio G, Mercurio G, Di Vittorio P, Tagliamonte A, Gessa GL. 1973. Letter: the effect of D-and L-p-chlorophenylalanine on the metabolism of 5-hydroxytryptamine in brain. J Pharm Pharmacol. 25:908-909.
28. Hariri AR, Holmes A. 2006. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 10:182-191.
29. Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A. 2008. Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci. 28:8074-8085.
30. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, Silver J, Weeber EJ, Sweatt JD, Deneris ES. 2003. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron. 37:233-247.
31. Holmes A. 2008. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci Biobehav Rev. 32:1293-1314.
32. Holmes A, Hariri AR. 2003. The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment. Genes Brain Behav. 2:332-335.
33. Holmes A, Wellman CL. 2009. Stress-induced prefrontal reorganization and executive dysfunction in rodents. Neurosci Biobehav Rev. 33:773-783.
34. Homberg JR, Pattij T, Janssen MC, Ronken E, De Boer SF, Schoffelmeer AN, Cuppen E. 2007. Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility. Eur J Neurosci. 26:2066-2073.
35. Izquierdo A, Newman TK, Higley JD, Murray EA. 2007. Genetic modulation of cognitive flexibility and socioemotional behavior in rhesus monkeys. Proc Natl Acad Sci USA. 104:14128-14133.
36. Izquierdo A, Wiedholz LM, Millstein RA, Yang RJ, Bussey TJ, Saksida LM, Holmes A. 2006. Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav Brain Res. 171:181-188.
37. Jedema HP, Gianaros PJ, Greer PJ, Kerr DD, Liu S, Higley JD, Suomi SJ, Olsen AS, Porter JN, Lopresti BJ, et al. 2009. Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. Mol Psychiatry. Advance Access published September 1, doi: 10.1038/mp.2009.90.
38. Jones B, Mishkin M. 1972. Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol. 36:362-377.
39. Jonsson G, Hallman H, Ponzio F, Ross S. 1981. DSP4 (N-(2-chloroethyl)-N- ethyl-2-bromobenzylamine)\a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol. 72:173-188.
40. Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A, Heilig M. 2008. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psycho-pharmacology (Berl). 195:547-557.
41. Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, Holmes A. 2009. Assessment of glutamate transporter GLAST (EAAT1)-de-ficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology. 34:1578-1589.
42. Lapiz-Bluhm MD, Soto-Pina AE, Hensler JG, Morilak DA. 2009. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl). 202:329-341.
43. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. 1983. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33:2609-2614.
44. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. 2004. Gene dose-dependent alterations in extra-neuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods. 140:169-181.
45. Millstein RA, Holmes A. 2007. Effects of repeated maternal separation on anxiety-and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev. 31:3-17.
46. Murray EA, O'Doherty JP, Schoenbaum G. 2007. What we know and do not know about the functions of the orbitofrontal cortex after 20 years of cross-species studies. J Neurosci. 27:8166-8169.
47. Norcross M, Poonam M, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA, Harvey-White J, Holmes A. 2008. Effects of adolescent fluoxetine treatment on fear-, anxiety-or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl). 200:413-424.
48. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ. 1994. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuro-pharmacology. 33:575-588.
49. Porsolt RD, Le Pichon M, Jalfre M. 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:730-732.
50. Robbins TW, Arnsten AF. 2009. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci. 32:267-287.
51. Roberts AC. 2006. Primate orbitofrontal cortex and adaptive behaviour. Trends Cogn Sci. 10:83-90.
52. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, et al. 1999. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl). 146:482-491.
53. Roiser JP, Rogers RD, Cook LJ, Sahakian BJ. 2006. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berl). 188:213-227.
54. Rudebeck PH, Murray EA. 2008. Amygdala and orbitofrontal cortex lesions differentially influence choices during object reversal learning. J Neurosci. 28:8338-8343.
55. Schoenbaum G, Shaham Y. 2008. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry. 63:256-262.
56. Seu E, Lang A, Rivera RJ, Jentsch JD. 2009. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology (Berl). 202:505-519.
57. Talbot PS, Watson DR, Barrett SL, Cooper SJ. 2006. Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting. Neuropsycho-pharmacology. 31:1519-1525.
58. Uher R, McGuffin P. 2008. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry. 13:131-146.
59. Vallender EJ, Lynch L, Novak MA, Miller GM. 2008. Polymorphisms in the 3' UTR of the serotonin transporter are associated with cognitive flexibility in rhesus macaques. Am J Med Genet B Neuropsychiatr Genet. 150B:467-475.
60. van der Plasse G, Feenstra MG. 2008. Serial reversal learning and acute tryptophan depletion. Behav Brain Res. 186:23-31.
61. Wellman CL, Izquierdo A, Garret JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. 2007. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci. 27:684-691.
62. Winstanley CA, Eagle DM, Robbins TW. 2006. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev. 26:379-395.